Category: CovidienSyndicate content

ArjoHuntleigh taps Covidien executive | Personnel Moves

July 19, 2013 by Sony Salzman

ArjoHuntleigh lured a former Covidien executive as its new president of North American operations.

fired/hired

Illinois healthcare products maker ArjoHuntleigh hired Rick Lytle, a former Covidien (NYSE:COV) executive, as the new president of company operations in the U.S. and Canada.

Covidien launches 2 trials to support its Stellarex drug-device combo

July 17, 2013 by Sony Salzman

Covidien begins enrollment in a pair of clinical studies evaluating its Stellarex drug-coated angioplasty balloon in the U.S. and abroad.

Covidien launched 2 trials to support its Stellarex drug-device combo

Covidien (NYSE:COV) kicked off 2 new clinical trials this week to support a global evaluation of its Stellarex drug-coated angioplasty balloon.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Emerging markets: MedTech heads to Africa

July 11, 2013 by MassDevice

S2N Health blogger Erin Warner travels to Africa for a look at the healthcare system. How can emerging medical device companies take advantage of this opportunity

By Erin Warner

disruptive tech

The large medtech companies talk endlessly about emerging markets delivering their top-line growth targets, and they are not just talking about BRIC countries anymore.

Medtech trends: The most talked about device makers in June 2013

July 3, 2013 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

MassDevice.com +3 | The top 3 med-tech stories for July 2, 2013

July 2, 2013 by Brad Perriello

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien could be on the hook for nearly $450M in back taxes

July 2, 2013 by Brad Perriello

Covidien could wind up with a nearly $450 million tax tab from its days as Tyco Healthcare, after the IRS nixes some $914 million in interest deductions dating back to the years 1997 through 2000.

Covidien could be on the hook for $384M in back taxes

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien puts a bow on pharma spinout, Wall Street backs off

July 1, 2013 by Arezu Sarvestani

Massachusetts-based Covidien officially becomes a pure-play medical device company after executing the spinout of its pharmaceuticals business into independently operated Mallinckrodt plc, which today began trading on the New York Stock Exchange.

Covidien and Mallinckrodt logos

Get the complete picture with a MassDevice Plus membership. Registered users can login here.